Short- and long-term effects of gestational diabetes mellitus on healthcare cost: A cross-sectional comparative study in the ATLANTIC DIP cohort

Diabetic Medicine

Volumn 32, Issue 4, 2015, Pages 467-476

  Danyliv, A ^a,b   Gillespie, P ^a   O'Neill, C ^a   Noctor, E ^b   O'Dea, A ^b,c   Tierney, M ^b,c   Mcguire, B ^b,c   Glynn, L G ^c   Dunne, F ^b,c  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; BODY MASS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CROSS-SECTIONAL STUDY; DELIVERY; DRUG USE; FEMALE; GLUCOSE TOLERANCE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MATERNAL CARE; MATERNAL SMOKING; NEWBORN CARE; PHYSIOTHERAPY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIMARY MEDICAL CARE; PRIMIPARA; QUESTIONNAIRE; DIABETES, GESTATIONAL; ECONOMICS; HEALTH SERVICE; PREGNANCY; REGRESSION ANALYSIS;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; FEMALE; HEALTH CARE COSTS; HUMANS; MATERNAL HEALTH SERVICES; PREGNANCY; REGRESSION ANALYSIS;

EID: 84924759941     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12678     Document Type: Article

References (23)

1. The Lancet. The global challenge of diabetes. The Lancet 2008; 371: 1723.
2. Reece EA, Leguizamón G, Wiznitzer A. Gestational diabetes: the need for a common ground. The Lancet 2009; 373: 1789-97.
3. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007; 30: S141-6.
4. O'Sullivan EP, Avalos G, O'Reilly M, Dennedy MC, Gaffney G, Dunne F. Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 2011; 54: 1670-5.
5. Gillespie P, Cullinan J, O'Neill C, Dunne F. Modeling the independent effects of gestational diabetes mellitus on maternity care and costs. Diabetes Care 2013; 36: 1111-16.
6. Gillespie P, O'Neill C, Avalos G, O'Reilly M, Dunne F, for the ADIPC. The cost of universal screening for gestational diabetes mellitus in Ireland. Diabet Med 2011; 28: 912-18.
7. Gillespie P, O'Neill C, Avalos G, Dunne FP, null. New estimates of the costs of universal screening for gestational diabetes mellitus in Ireland. Ir Med J 2012; 105(Suppl 5): 15-18.
8. The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991-2002.
9. Bellamy L, Casas J-P, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. The Lancet 2009; 373: 1773-9.
10. Egeland GM, Meltzer SJ. Following in mother's footsteps? Mother-daughter risks for insulin resistance and cardiovascular disease 15 years after gestational diabetes. Diabet Med 2010; 27: 257-65.
11. Gillman MW, Rifas-Shiman S, Berkey CS, Field AE, Colditz GA. Maternal gestational diabetes, birth weight, and adolescent obesity. Pediatrics 2003; 111: e221-6.
12. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles M-A, Pettitt DJ. Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia. Diabetes Care 2007; 30: 2287-92.
13. Plagemann A, Harder T, Kohlhoff R, Rohde W, Dörner G. Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes. Diabetologia 1997; 40: 1094-100.
14. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676-82.
15. Kavanagh K, O'Brien N, Glynn L, Vellinga A, Murphy A. WestREN: a description of an Irish academic general practice research network. BMC Fam Pract 2010; 11: 74.
16. Casemix/HIPE. Irish Casemix Programme. 2014. Available at http://www.casemix.ie/ Last accessed 26 July 2011.
17. Health Information and Quality Authority. Guidelines for the Economic Evaluation of Health Technologies in Ireland. 2010. Available at http://www.hiqa.ie/publication/guidelines-economic-evaluation-health-technologies-ireland Last accessed 26 December 2014.
18. HSE. Payscales. 2013. Available at http://www.hse.ie/eng/staff/Benefits_Services/pay/ Last accessed 26 December 2014.
19. Monthly Index of Medical Specialities (MIMS) Ireland. Dublin: MPI Media Ltd, 2012.
20. Torrance GW, Drummond MF. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 2005.
21. Glick H. Economic Evaluation in Clinical Trials. Oxford: Oxford University Press, 2007.
22. Xiong X, Saunders LD, Wang FL, Demianczuk NN. Gestational diabetes mellitus: prevalence, risk factors, maternal and infant outcomes. Int J Gynaecol Obstet 2001; 75: 221-8.
23. Long H. Diagnosing gestational diabetes: can expert opinions replace scientific evidence? Diabetologia 2011; 54: 2211-13.